Showing results (1-10 of 252) with videos related to
Sort By:
Pageof 26
Current Opinion in Hematology|February 24, 2010
Novel approaches for myelodysplastic syndromes: beyond hypomethylating agentsArturo Loaiza-Bonilla, Steven D Gore, Hetty E CarrawayBritish Journal of Haematology|October 30, 2016
A phase 2 trial of high dose lenalidomide in patients with relapsed/refractory higher-risk myelodysplastic syndromes and acute myeloid leukaemia with trilineage dysplasiaAmer M Zeidan, B Douglas Smith, Hetty E Carraway, et al.Hematology. American Society of Hematology. Education Program|December 4, 2016
Treatment options for patients with myelodysplastic syndromes after hypomethylating agent failureHetty E CarrawayHematology. American Society of Hematology. Education Program|December 5, 2025
Updates in low/intermediate-risk MDSHetty E CarrawayJournal of Hematology & Oncology|April 20, 2017
Emerging therapies for acute myeloid leukemiaCaner Saygin, Hetty E CarrawayCancer Journal (Sudbury, Mass.)|May 17, 2023
Overview of the Management of Higher-Risk Myelodysplastic SyndromesAbhay Singh, Hetty E CarrawayHematology. American Society of Hematology. Education Program|December 4, 2020
Therapy for lower-risk MDSHetty E Carraway, Caner SayginBest Practice & Research. Clinical Haematology|October 11, 2020
Myeloid neoplasms with germline predisposition: Practical considerations and complications in the search for new susceptibility lociHetty E Carraway, Thomas LaFramboiseBlood Reviews|January 11, 2021
Current and emerging strategies for management of myelodysplastic syndromesCaner Saygin, Hetty E CarrawayCurrent Treatment Options in Oncology|June 25, 2024
Treatment of Relapsed Acute Lymphocytic Leukemia in Adult PatientsJohn C Molina, Hetty E CarrawayPageof 26